Pluri Inc. Increase (Decrease) in Interest Payable, Net
Pluri Inc. (PLUR) reported Increase (Decrease) in Interest Payable, Net of $142.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2026-09-10
- Pluri Inc. increase (decrease) in interest payable, net for the quarter ending 2026-06-30 was $18.00K, a 99.23% decline year-over-year.
- Pluri Inc. increase (decrease) in interest payable, net for the quarter ending 2026-03-31 was -$369.00K, a 132.09% decline year-over-year.
- Pluri Inc. increase (decrease) in interest payable, net for the quarter ending 2025-12-31 was $241.00K.
- Pluri Inc. increase (decrease) in interest payable, net for the quarter ending 2025-09-30 was $252.00K, a 81.17% decline year-over-year.
- Pluri Inc. increase (decrease) in interest payable, net for fiscal 2026 was $142.00K, a 95.65% decline from fiscal 2025.
- Pluri Inc. increase (decrease) in interest payable, net for fiscal 2025 was $3.26M, a 556.34% increase from fiscal 2024.
- Pluri Inc. increase (decrease) in interest payable, net for fiscal 2024 was $497.00K, a 73.16% decline from fiscal 2023.
- Pluri Inc. increase (decrease) in interest payable, net for fiscal 2023 was $1.85M.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 3 month as first filed | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 6 month as first filed | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 9 month as first filed | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | -$351.00K derived: sum of 2 quarters · filed 2026-09-10 | -$110.00K derived: sum of 3 quarters · filed 2026-09-10 | $142.00K 10-K · filed 2026-09-10 | |||
| 2026-03-31 | -$369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$128.00K derived: sum of 2 quarters · filed 2026-05-14 | $124.00K 10-Q · filed 2026-05-14 | $2.46M derived: sum of 4 quarters · filed 2026-09-10 | |||
| 2025-12-31 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | $493.00K 10-Q · filed 2026-02-12 | $2.83M derived: sum of 3 quarters · filed 2026-09-10 | $3.98M derived: sum of 4 quarters · filed 2026-09-10 | |||
| 2025-09-30 | $252.00K 10-Q · filed 2025-11-12 | $2.59M derived: sum of 2 quarters · filed 2026-09-10 | $3.74M derived: sum of 3 quarters · filed 2026-09-10 | $2.18M derived: sum of 4 quarters · filed 2026-09-10 | |||
| 2025-06-30 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $3.49M derived: sum of 2 quarters · filed 2026-09-10 | $1.92M derived: sum of 3 quarters · filed 2026-09-10 | $3.26M 10-K · filed 2026-09-10 | |||
| 2025-03-31 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$417.00K derived: sum of 2 quarters · filed 2026-05-14 | $921.00K 10-Q · filed 2026-05-14 | $883.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$229.00K 10-Q · filed 2026-02-12 | -$267.00K derived: sum of 3 quarters · filed 2026-02-12 | -$601.00K derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-09-30 | $1.34M 10-Q · filed 2025-11-12 | $1.30M derived: sum of 2 quarters · filed 2025-11-12 | $966.00K derived: sum of 3 quarters · filed 2025-11-12 | $2.19M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | -$372.00K derived: sum of 2 quarters · filed 2025-09-17 | $855.00K derived: sum of 3 quarters · filed 2025-09-17 | $497.00K 10-K · filed 2025-09-17 | |||
| 2024-03-31 | -$334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $893.00K derived: sum of 2 quarters · filed 2025-05-13 | $535.00K 10-Q · filed 2025-05-13 | $719.00K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | $869.00K 10-Q · filed 2025-02-11 | $871.00K 10-Q · filed 2024-02-12 | $1.05M derived: sum of 3 quarters · filed 2025-02-11 | $1.72M derived: sum of 4 quarters · filed 2025-02-11 | ||
| 2023-09-30 | -$358.00K 10-Q · filed 2024-11-12 | -$174.00K derived: sum of 2 quarters · filed 2024-11-12 | $497.00K derived: sum of 3 quarters · filed 2024-11-12 | $2.45M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $855.00K derived: sum of 2 quarters · filed 2024-09-18 | $2.81M derived: sum of 3 quarters · filed 2024-09-18 | $1.85M 10-K · filed 2024-09-18 | |||
| 2023-03-31 | $671.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-09 | $2.63M derived: sum of 2 quarters · filed 2024-05-09 | $1.67M 10-Q · filed 2024-05-09 | $440.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-12 | $997.00K 10-Q · filed 2024-02-12 | -$231.00K derived: sum of 3 quarters · filed 2024-02-12 | -$429.00K derived: sum of 4 quarters · filed 2024-02-12 | |||
| 2022-09-30 | -$957.00K 10-Q · filed 2023-11-13 | -$2.19M derived: sum of 2 quarters · filed 2023-11-13 | -$2.38M derived: sum of 3 quarters · filed 2023-11-13 | -$2.72M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$1.43M derived: sum of 2 quarters · filed 2023-09-12 | -$1.77M derived: sum of 3 quarters · filed 2023-09-12 | -$2.17M 10-K · filed 2023-09-12 | |||
| 2022-03-31 | -$198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | -$538.00K derived: sum of 2 quarters · filed 2023-05-09 | -$944.00K 10-Q · filed 2023-05-09 | -$926.00K 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | -$340.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-13 | -$746.00K 10-Q · filed 2023-02-13 | -$692.00K 10-Q · filed 2022-02-07 | ||||
| 2021-09-30 | -$406.00K 10-Q · filed 2022-11-10 | $228.00K 10-Q · filed 2021-11-08 | |||||
| 2021-06-30 | $78.00K 10-K · filed 2022-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |